￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Study on the adverse reactions of erlotinib in patients with lung adenocarcinoma

2026-02-01 22:25:32

Check Details
Erlotinib belongs to the first generation of targeted drugs

2026-02-01 22:25:32

Check Details
What is erlotinib?

2026-02-01 22:25:32

Check Details
How to treat erlotinib side effects

2026-02-01 22:25:32

Check Details
Detailed explanation of the cost of imatinib targeted drug

2026-02-01 22:25:32

Check Details
Is imatinib a targeted drug?

2026-02-01 22:25:32

Check Details
Analysis of imatinib price and medical insurance reimbursement details

2026-02-01 22:25:32

Check Details
Imatinib 2024 Price Update and Buying Guide

2026-02-01 22:25:32

Check Details
Imatinib medical insurance coverage and drug purchase guide

2026-02-01 22:25:32

Check Details
tyrosine kinase inhibitor imatinib

2026-02-01 22:25:32

Check Details
Imatinib has significant efficacy but requires careful analysis of side effects

2026-02-01 22:25:32

Check Details
Imatinib usage guidelines and precautions

2026-02-01 22:25:32

Check Details
Category
相关知识